IP Library Granted Patent US 7,648,844
Granted Patent B2
US 7,648,844 · App. 11/416,789 · Granted Jan 19, 2010

Method and apparatus for detection of analyte using an acoustic device

Assignee: BioScale, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,648,844
App. No.
11/416,789
Granted
Jan 19, 2010
Kind
B2
Abstract

Methods for detecting analytes in a sample are provided. A plurality of particles, each of which is coated with a capture agent having an affinity for the analyte, is combined with the sample to form a plurality of analyte-particle complexes. The system also includes a transport arrangement for transporting the sample to the sensor surface, and a magnetic field inducing structure constructed and arranged to establish a magnetic field at and adjacent to the sensor surface. The resonant sensor produces a signal corresponding to an amount of analyte-particle complexes that are bound to the sensor surface.

Claims (23)

1. A method for detecting whether one or more analytes is present in a sample comprising:

a) introducing a fluid comprising a sample, a plurality of magnetic particles and a competitor molecule into a fluid chamber, said magnetic particles being coated with a first capture agent capable of binding the analyte, wherein at least one surface of the fluid chamber comprises a flexural plate wave device that has been coated with a second capture agent capable of binding to the competitor molecule, wherein the flexural plate wave device has a membrane that is capable of vibrating, and wherein the second capture agent is bound to the membrane;

b) applying a retractable source of magnetic flux positioned external to the fluid chamber close to the membrane to create a significant magnetic field gradient to attract at least one of the plurality of magnetic particles in the fluid toward the membrane;

c) monitoring a first signal output by the flexural plate wave device, wherein the first signal output is monitored in the presence of a magnetic flux;

d) after removing the retractable source of magnetic flux, flowing a solution through the fluid chamber to remove magnetic particles not bound to the membrane;

e) monitoring a second signal output by said flexural plate wave device, wherein the second signal output is monitored in the absence of the magnetic flux; and

f) comparing the first and the second signal output to a control signal, thereby detecting whether one or more analytes is present in the sample.

2. The method of claim 1 , wherein prior to being introduced into the fluid chamber, said plurality of magnetic particles has been exposed to the sample and to the competitor molecule.

3. The method of claim 1 , wherein the competitor molecule comprises the immunosuppressant bound to a tag and the second capture agent is capable of binding to the tag.

4. The method of claim 3 , wherein the tag is biotin.

5. The method of claim 1 , wherein the competitor molecule comprises two or more analyte molecules bound to a carrier, and the second capture agent is capable of binding the analyte.

6. The method of claim 5 , wherein the carrier is a selected from the group consisting of horseradish peroxidase and albumin.

7. The method of claim 1 , wherein the sample and the competitor molecule have been introduced into the fluid chamber prior to introducing the plurality of magnetic particles.

8. The method of claim 1 , wherein the sample is a biological sample.

9. The method of claim 8 , wherein the biological sample is selected from the group consisting of: saliva, sputum, cerebrospinal fluid, blood, serum, plasma, urine, and biopsy material.

10. The method of claim 1 , wherein the control signal is a standard curve.

11. The method of claim 1 , wherein the control signal is obtained without the sample.

12. The method of claim 1 , wherein the second capture agent is indirectly bound to said surface.

13. The method of claim 12 , wherein said surface is coated with a first member of a binding pair, and the second capture agent is bound to a second member of the binding pair.

14. The method of claim 13 , wherein the first member of the binding pair is biotin.

15. The method of claim 1 , wherein the first or second capture agent is an antibody.

16. The method of claim 13 , wherein the second member of the binding pair is a derivative of avidin.

17. The method of claim 1 , wherein a fluid flows across the membrane during one or more of steps of a), b), c) and e).

Assignments (2)
CHANGE OF NAME Recorded Jun 17, 2016
From: BIOSCALE, INC.
To: PROTERIXBIO, INC.
Reel/Frame 039069/0923 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 19, 2006
From: SRIVASTAVA, ALOK; WANG, WAYNE U.; MILLER, MICHAEL; MASTERS, BRETT P.; LUNDSTROM, MARK
To: BIOSCALE, INC.
Reel/Frame 018270/0306 →
Continuity (4)
Continuation In Part 1118348400 · Jul 18, 2005
Provisional Application 6069059200 · Jun 15, 2005
Provisional Application 6067675900 · May 2, 2005
Related Publication 20090148857A1 · Jun 11, 2009